

浏览全部资源
扫码关注微信
1.延边大学药学院,吉林 延吉 133002
2.军事医学科学院毒物药物研究所,北京 100850
Received:04 August 2023,
Revised:2024-03-17,
Accepted:18 March 2024,
Published:15 April 2024
移动端阅览
邵天娇,金莉莉,王珊,等.曲安奈德给药途径及相应剂型的研究进展[J].中国药房,2024,35(07):896-900.
SHAO Tianjiao,JIN Lili,WANG Shan,et al.Research progress in the route of administration and corresponding dosage form of triamcinolone acetonide[J].ZHONGGUO YAOFANG,2024,35(07):896-900.
邵天娇,金莉莉,王珊,等.曲安奈德给药途径及相应剂型的研究进展[J].中国药房,2024,35(07):896-900. DOI: 10.6039/j.issn.1001-0408.2024.07.23.
SHAO Tianjiao,JIN Lili,WANG Shan,et al.Research progress in the route of administration and corresponding dosage form of triamcinolone acetonide[J].ZHONGGUO YAOFANG,2024,35(07):896-900. DOI: 10.6039/j.issn.1001-0408.2024.07.23.
曲安奈德作为一种临床应用广泛的糖皮质激素药物,可以通过眼部、鼻腔、关节腔、皮肤等多途径给药,用于治疗关节炎、黄斑水肿、鼻炎、荨麻疹等多种局部疾病。曲安奈德作为一种在水中溶解度极低的药物,剂型与给药途径、给药部位息息相关。曲安奈德经注射(包括关节腔注射、玻璃体注射、脉络膜上腔注射、肌内注射)给药的剂型主要为混悬剂,代表性药物包括Kenalog-40
®
、Zilretta
®
、Triesence
®
、Xipere
®
等;鼻腔黏膜给药的剂型多为喷雾剂,代表性药物为Nasacort
®
;口腔黏膜给药的剂型多为贴剂、软膏
剂和乳膏剂,代表性药物为Oracort
®
;经皮给药的剂型多为软膏剂、乳膏剂和洗剂,代表性药物包括Trianex
®
、Teva-Triacomb
®
等。现阶段有关曲安奈德各种给药途径的剂型研究主要围绕递送载体的构建、增加助溶剂或借助新型递送工具等展开。
As a glucocorticoid drug with wide clinical application, triamcinolone acetonide can be administered by multiple routes, such as eye, nose, joint cavity, and skin, for the treatment of various local diseases such as arthritis, macular edema, rhinitis, and urticaria. As a drug with extremely low solubility in water, the dose form of triamcinolone acetonide is closely correlated with administration route and site. The dosage form of triamcinolone acetonide administered via injection(including joint cavity injection, vitreous injection, suprachoroidal injection, intramuscular injection) is mainly suspension, and the representative drugs include Kenalog-40
®
, Zilretta
®
, Triesence
®
, Xipere
®
, etc.; the dosage forms of nasal mucosal administration are mostly sprays, and the representative drug is Nasacort
®
; the dosage forms of oral mucosal administration are mostly patches, ointments and creams, and the representative drug is Oracort
®
; the dosage forms for transdermal administration are mostly ointments, creams and lotions, and the representative drugs include Trianex
®
, Teva-Triacomb
®
, etc. At present, the research on dosage forms of triamcinolone acetonide by various administration routes mainly focuses on the construction of delivery carriers, the addition of cosolvents or the use of new delivery tools.
SARAO V , VERITTI D , BOSCIA F , et al . Intravitreal steroids for the treatment of retinal diseases [J ] . Sci World J , 2014 , 2014 : 989501 .
SELLAM J , BERENBAUM F . The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis [J ] . Nat Rev Rheumatol , 2010 , 6 ( 11 ): 625 - 635 .
FUNG S , SYED Y Y . Suprachoroidal space triamcinolone acetonide:a review in uveitic macular edema [J ] . Drugs , 2022 , 82 ( 13 ): 1403 - 1410 .
ALVES J C , SANTOS A , JORGE P , et al . A pilot study on the efficacy of a single intra-articular administration of triamcinolone acetonide,hyaluronan,and a combination of both for clinical management of osteoarthritis in police working dogs [J ] . Front Vet Sci , 2020 , 7 : 512523 .
TIPNIS N P , SHEN J , JACKSON D , et al . Flow-through cell-based in vitro release method for triamcinolone acetonide poly (lactic-co-glycolic) acid microspheres [J ] . Int J Pharm , 2020 , 579 : 119130 .
MCALINDON T E , LAVALLEY M P , HARVEY W F , et al . Effect of intra-articular triamcinolone vs. saline on knee cartilage volume and pain in patients with knee osteoarthritis:a randomized clinical trial [J ] . JAMA , 2017 , 317 ( 19 ): 1967 - 1975 .
WISE J . Steroid injections for knee osteoarthritis are not supported by study [J ] . BMJ , 2017 , 357 : j2386 .
KATZ J N , ARANT K R , LOESER R F . Diagnosis and treatment of hip and knee osteoarthritis:a review [J ] . JAMA , 2021 , 325 ( 6 ): 568 - 578 .
RILLO O , RIERA H , ACOSTA C , et al . PANLAR consensus recommendations for the management in osteoarthritis of hand,hip,and knee [J ] . J Clin Rheumatol , 2016 , 22 ( 7 ): 345 - 354 .
PAIK J , DUGGAN S T , KEAM S J . Triamcinolone acetonide extended-release:a review in osteoarthritis pain of the knee [J ] . Drugs , 2019 , 79 ( 4 ): 455 - 462 .
SHE P , BIAN S , CHENG Y Q , et al . Dextran sulfate-triamcinolone acetonide conjugate nanoparticles for targeted treatment of osteoarthritis [J ] . Int J Biol Macromol , 2020 , 158 : 1082 - 1089 .
HABIB G , SAFIA A . The effect of intra-articular injection of betamethasone acetate/betamethasone sodium pho- sphate on blood glucose levels in controlled diabetic patients with symptomatic osteoarthritis of the knee [J ] . Clin Rheumatol , 2009 , 28 ( 1 ): 85 - 87 .
KRAUS V B , CONAGHAN P G , AAZAMI H A , et al . Synovial and systemic pharmacokinetics (PK) of triamcinolone acetonide (TA) following intra-articular (IA) injection of an extended-release microsphere-based formulation (FX006) or standard crystalline suspension in patients with knee osteoarthritis (OA) [J ] . Osteoarthr Cartilage , 2018 , 26 ( 1 ): 34 - 42 .
朱开元 , 徐翰南 , 王云 , 等 . 关节腔内药物递送系统研究进展 [J ] . 国际骨科学杂志 , 2020 , 41 ( 5 ): 271 - 274,302 .
ZHU K Y , XU H N , WANG Y , et al . Advances in intra-articular drug delivery system [J ] . Int J Orthop , 2020 , 41 ( 5 ): 271 - 274,302 .
SEO B B , KWON Y , KIM J , et al . Injectable polymeric nanoparticle hydrogel system for long-term anti-inflammatory effect to treat osteoarthritis [J ] . Bioact Mater , 2022 , 7 : 14 - 25 .
VALDES L M , SOBRIN L . Uveitis therapy:the corticosteroid options [J ] . Drugs , 2020 , 80 ( 8 ): 765 - 773 .
DIKMETAS O , KUEHLEWEIN L , GELISKEN F . Rebound phenomenon after intravitreal injection of triamcinolone acetonide for macular edema [J ] . Ophthalmologica , 2020 , 243 ( 6 ): 420 - 425 .
KATO F , NOZAKI M , KATO A , et al . Retinal microvascular changes after intravitreal triamcinolone acetonide in diabetic macular edema [J ] . J Clin Med , 2023 , 12 ( 10 ): 3475 .
JEAL W , FAULDS D . Triamcinolone acetonide. A review of its pharmacological properties and therapeutic efficacy in the management of allergic rhinitis [J ] . Drugs , 1997 , 53 ( 2 ): 257 - 280 .
FORBES B , BOMMER R , GOOLE J , et al . A consensus research agenda for optimizing nasal drug delivery [J ] . Expert Opin Drug Deliv , 2020 , 17 ( 2 ): 127 - 132 .
SALLAM M A , HELAL H M , MORTADA S M . Ra- tionally designed nanocarriers for intranasal therapy of allergic rhin itis:influence of carrier type on in vivo nasal deposition [J ] . Int J Nanomedicine , 2016 , 11 : 2345 - 2357 .
PEÑA M A . Solubilization and controlled release strategy of poorly water-soluble drugs [J ] . Pharmaceuticals , 2022 , 15 ( 11 ): 1353 .
KUMAR M , KUMAR D , KUMAR S , et al . A recent review on bio-availability enhancement of poorly water-soluble drugs by using bioenhancer and nanoparticulate drug delivery system [J ] . Curr Pharm Des , 2022 , 28 ( 39 ): 3212 - 3224 .
TAULU R , NUMMINEN J , BIZAKI A , et al . Image-guided,navigation-assisted Relieva Stratus MicroFlow spacer insertion into the ethmoid sinus [J ] . Eur Arch Otorhinolaryngol , 2015 , 272 ( 9 ): 2335 - 2340 .
VANDEWALLE J , LUYPAERT A , DE BOSSCHER K , et al . Therapeutic mechanisms of glucocorticoids [J ] . Trends Endocrinol Metab , 2018 , 29 ( 1 ): 42 - 54 .
NANIWA M , NAKATOMI C , HITOMI S , et al . Analgesic mechanisms of steroid ointment against oral ulcerative mucositis in a rat model [J ] . Int J Mol Sci , 2021 , 22 ( 22 ): 12600 .
LAM J K , XU Y Y , WORSLEY A , et al . Oral transmucosal drug delivery for pediatric use [J ] . Adv Drug Deliv Rev , 2014 , 73 : 50 - 62 .
THANTAVIRIYA S , KAMANAMOOL N , SANSUREERUNGSIKUL T , et al . Efficacy and safety of detachable microneedle patch containing triamcinolone acetonide in the treatment of inflammatory acne [J ] . Clin Cosmet Investig Dermatol , 2023 , 16 : 1431 - 1441 .
YIM S G , SEONG K Y , THAMARAPPALLI A , et al . Fast-embeddable grooved microneedles by shear actuation for accurate transdermal drug delivery [J ] . Pharmaceutics , 2023 , 15 ( 7 ): 1966 .
QU X Y , GUO X L , ZHU T T , et al . Microneedle patches containing mesoporous polydopamine nanoparticles loaded with triamcinolone acetonide for the treatment of oral mucositis [J ] . Front Bioeng Biotechnol , 2023 , 11 : 1203709 .
PENG C L , LIU C , TANG X . Determination of physicochemical properties and degradation kinetics of triamcinolone acetonide palmitate in vitro [J ] . Drug Dev Ind Pharm , 2010 , 36 ( 12 ): 1469 - 1476 .
DISPHANURAT W , SIVAPORNPAN N , SRISANTITHUM B , et al . Efficacy of triamcinolone acetonide-loaded dissolving microneedle patch for the treatment of hypertrophic scars and keloids:a randomized,double-blinded,placebo-controlled split-scar study [J ] . Arch Dermatol Res , 2023 , 315 ( 4 ): 989 - 997 .
JANG M , KANG B M , YANG H , et al . High-dose steroid dissolving microneedle for relieving atopic dermatitis [J ] . Adv Healthc Mater , 2021 , 10 ( 7 ): e2001691 .
WANG H , FU Y X , LIU P , et al . Supramolecular dissol- ving microneedle patch loading hydrophobic glucocorticoid for effective psoriasis treatment [J ] . ACS Appl Mater Interfaces , 2023 , 15 ( 12 ): 15162 - 15171 .
0
Views
19
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
公网安备50010302001817